The Centers for Medicare & Medicaid Services Dec. 29 announced $50 billion in funds awarded to all 50 states through the Rural Health Transformation Program.
If COVID-19 antibody drugs are authorized by the FDA, CMS will cover the costs for Medicare beneficiaries, and HHS will distribute it to hospitals in a method similar to its distribution of Gilead’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback